Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8UD7

Crystal structure of the A2058-N6-dimethylated Thermus thermophilus 70S ribosome in complex with cresomycin, mRNA, deacylated A-site tRNAphe, aminoacylated P-site fMet-tRNAmet, and deacylated E-site tRNAphe at 2.70A resolution

This is a non-PDB format compatible entry.
Summary for 8UD7
Entry DOI10.2210/pdb8ud7/pdb
Descriptor23S Ribosomal RNA, 50S ribosomal protein L14, 50S ribosomal protein L15, ... (61 entities in total)
Functional Keywordscresomycin, lincosamides, structure-based drug design, antibiotic, resistance, cfr, erm, methylation, a2058, a2503, 23s rrna, 70s ribosome, inhibition of translation, peptidyl transferase center, nascent peptide exit tunnel, ribosome, ribosome-rna complex, ribosome/rna
Biological sourceEscherichia coli
More
Total number of polymer chains112
Total formula weight4568498.22
Authors
Primary citationWu, K.J.Y.,Tresco, B.I.C.,Ramkissoon, A.,Aleksandrova, E.V.,Syroegin, E.A.,See, D.N.Y.,Liow, P.,Dittemore, G.A.,Yu, M.,Testolin, G.,Mitcheltree, M.J.,Liu, R.Y.,Svetlov, M.S.,Polikanov, Y.S.,Myers, A.G.
An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance.
Science, 383:721-726, 2024
Cited by
PubMed Abstract: We report the design conception, chemical synthesis, and microbiological evaluation of the bridged macrobicyclic antibiotic cresomycin (CRM), which overcomes evolutionarily diverse forms of antimicrobial resistance that render modern antibiotics ineffective. CRM exhibits in vitro and in vivo efficacy against both Gram-positive and Gram-negative bacteria, including multidrug-resistant strains of , , and . We show that CRM is highly preorganized for ribosomal binding by determining its density functional theory-calculated, solution-state, solid-state, and (wild-type) ribosome-bound structures, which all align identically within the macrobicyclic subunits. Lastly, we report two additional x-ray crystal structures of CRM in complex with bacterial ribosomes separately modified by the ribosomal RNA methylases, chloramphenicol-florfenicol resistance (Cfr) and erythromycin-resistance ribosomal RNA methylase (Erm), revealing concessive adjustments by the target and antibiotic that permit CRM to maintain binding where other antibiotics fail.
PubMed: 38359125
DOI: 10.1126/science.adk8013
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.55 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon